Cash Crunch
Sarepta Sells $174 Million Stake in Arrowhead to Fund Milestone Payment Amid Cash Crunch
Sarepta Therapeutics; Arrowhead Pharmaceuticals; cash crunch; stake sale; milestone payment; RNAi collaboration; SRP-1003; myotonic dystrophy; private block trade
Imunon Halts COVID-19 Vaccine Program, Seeks Partner Due to Financial Struggles
Imunon; COVID-19 vaccine; IMNN-101; deprioritization; cash crunch; partnership; financial results